Search company, investor...
Search
Citagenix company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

citagenix.com

Investors Count

2

Deal Terms

1

Citagenix Funding, Citagenix Valuation & Citagenix Revenue

2 Fundings

Citagenix's latest funding round was a Acquired for on May 2, 2022.

Citagenix's latest post-money valuation is from May 2022.

Sign up for a free trial to see Citagenix's valuations in May 2022 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

5/2/2022

Acquired

$99M

0

FY undefined

1

10/16/2015

Corporate Majority

0

FY undefined

10

Date

5/2/2022

10/16/2015

Round

Acquired

Corporate Majority

Amount

Investors

Valuation

$99M

Revenue

0

FY undefined

0

FY undefined

Sources

1

10

Citagenix Deal Terms

1 Deal Term

Citagenix's deal structure is available for 1 funding round, including their Acquired from May 02, 2022.

Round

Acquired

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

$99M

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acquired

$99M

$99M

$99M

$99M

Citagenix Investors

2 Investors

Citagenix has 2 investors. HANSAmed invested in Citagenix's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

5/2/2022

5/2/2022

1
Acquired

Corporation

Canada

00/00/0000

00/00/0000

Antibe Therapeutics

Subscribe to see more

Corporation

Canada

First funding

5/2/2022

00/00/0000

Last Funding

5/2/2022

00/00/0000

Investor

Antibe Therapeutics

Rounds

1
Acquired

Subscribe to see more

Board Seats

Type

Corporation

Corporation

Location

Canada

Canada

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.